Clinical Articles and Instructions for Use
Journal Articles Pertinent To RPA
The below links will take you to journal articles published on the “active ingredients” in RPA.
Multi-Tissue DNA Aging and DNA Methylation
- DNA Methylation Biomarkers in Aging and Age-Related Diseases
- The Hallmarks of Aging
- Histone Lysine Methylation and Long Non-Coding RNA: The New Target Players in Skeletal Muscle Cell Regeneration
- Epigenetic reprogramming during tissue regeneration
- Aging and DNA methylation
- MicroRNAs as modulators of longevity and the aging process
- Recent studies referring to miRNAs that directly target DKK1 and their association with certain disorders/biological processes
Cognition
- Human umbilical msc-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke
- Regulatory microRNAs and vascular cognitive impairment and dementia
- A microRNA signature that correlates with cognition and is a target against cognitive decline
- MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases
Orthopedic
- MicroRNA engineered umbilical cord stem cell-derived exosomes direct tendon regeneration by mTOR signaling
- The Roles of MicroRNAs in Tendon Healing and Regeneration
- Role of microRNA in muscle regeneration and diseases related to muscle dysfunction in atrophy, cachexia, osteoporosis, and osteoarthritis
Degenerative Disc Disease
- MicroRNA-140-3p alleviates intervertebral disc degeneration via KLF5/N-cadherin/MDM2/Slug axis
- Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
Athletes’ Cartilage Methylate Earlier
miRNA Turn On Regenerative Messages.
Auto-Immune / Multi-Tissue Source / RNA
Clinical Journal Articles Pertinent to MUSE Cells/Proteins
Clinical Journal Articles Pertinent to PGX / NGX Testing
Pharmacogenomic Journal Articles
- Pharmacogenomics for Improved Outcomes and Decreased Costs in Health Care
- Utility of Pharmacogenomic Testing To Optimise Antidepressant Pharmacotherapy in Youth
- Pharmacogenomic Testing Brings Real-World Benefits for Depression Treatment
- Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, Opioids, and Codeine/Tramadol
- Pharmacogenetic Approaches in Personalized Medicine for Postoperative Pain
Nutrigenomic Journal Articles
- Nutrigenomics: From Promise to Practice
- Nutrigenomics and the Future of Nutrition
- Personalized Nutrition by Prediction of Glycemic Responses
- Randomized Trial of Genetic Information for Personalized Nutrition
- Nutrigenomics Care Map
- The Power of Nutrigenomics and How Personalized Nutrition Supports Longevity
MUSE Infused RPA IFU’s
RPA Scaffolding IFU’s
RPA IFU’s
Pharmacogenomic & Nutrigenomic Testing (PGX/NGX) IFU’s
Push Patch Needle-Free Peptide IFU’s
Module 3
The statements on this page have not been evaluated by the Food and Drug Administration. Genesis Regenerative is providing this information for educational purposes only, does not practice medicine, nor make claims to the ability of any of its products to diagnose, treat, cure or prevent any disease. Only a licensed and qualified clinician and their patient can decide if a specific therapy is right for their healthcare needs. Please consult with your healthcare provider before using any product or therapy.